Bioiasis AD (XBUL:BIOA) Scaled Net Operating Assets: 2.05 (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBUL:BIOA Bioiasis AD XBUL:BIOA
12 GF Score
Price €8.25
! 1 Warning Sign
View Full Analysis

What is Bioiasis AD Scaled Net Operating Assets?

Bioiasis AD XBUL:BIOA 12 Scaled Net Operating Assets is 2.05 as of Sep. 2025. GuruFocus rates XBUL:BIOA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bioiasis AD's operating assets for the quarter that ended in Sep. 2025 was €23.10 Mil. Bioiasis AD's operating liabilities for the quarter that ended in Sep. 2025 was €1.67 Mil. Bioiasis AD's Total Assets for the quarter that ended in Jun. 2025 was €10.47 Mil. Therefore, Bioiasis AD's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2025 was 2.05.


Bioiasis AD Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Bioiasis AD's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioiasis AD Scaled Net Operating Assets Chart

Bioiasis AD Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.02 -0.02 22.92 0.94

Bioiasis AD Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.94 0.65 0.68 2.05

XBUL:BIOA vs ABT, SYK, MDT: Scaled Net Operating Assets Comparison

For the Medical Devices subindustry, Bioiasis AD's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioiasis AD Scaled Net Operating Assets vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioiasis AD's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Bioiasis AD's Scaled Net Operating Assets falls into.


XBUL:BIOA
12GF Score
Bioiasis AD XBUL:BIOA
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioiasis AD Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bioiasis AD's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(10.573-3.235)/7.834
=0.94

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=10.606 - 0.033
=10.573

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=10.361 - 4.975 - 2.151
=3.235

Bioiasis AD's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2025 )
=(Operating Assets (Q: Sep. 2025 )-Operating Liabilities (Q: Sep. 2025 ))/Total Assets (Q: Jun. 2025 )
=(23.097-1.665)/10.466
=2.05

where

Operating Assets(Q: Sep. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=24.086 - 0.989
=23.097

Operating Liabilities(Q: Sep. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=23.753 - 19.824 - 2.264
=1.665

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 2.05 mean?
Bioiasis AD (XBUL:BIOA) has a Scaled Net Operating Assets of 2.05 as of Sep. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Bioiasis AD and its competitors.
Is Bioiasis AD's Scaled Net Operating Assets too high?
Bioiasis AD's current Scaled Net Operating Assets is 2.05. Overall, Bioiasis AD has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioiasis AD's Scaled Net Operating Assets compare to ABT and SYK?
Bioiasis AD's Scaled Net Operating Assets of 2.05 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Bioiasis AD and its competitors. Bioiasis AD's current Scaled Net Operating Assets is 2.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioiasis AD stock overvalued right now?
Bioiasis AD (XBUL:BIOA) has a current Scaled Net Operating Assets of 2.05. The current Scaled Net Operating Assets is 2.05. Bioiasis AD's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Bioiasis AD (XBUL:BIOA), the current Scaled Net Operating Assets is 2.05 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioiasis AD Business Description

Address 60, Deyan Belishki Str., Ground Floor, Sofia, BGR, 1404
Bioiasis AD provides specialized medical devices, equipment, and consultation services to state and private hospitals and trading companies. The company also deals in Interventional Cardiology and General Surgery consumables.
12GF Score

Get the complete analysis for XBUL:BIOA

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.25
Price